Servier
| Candidate | Targets | Indication | Partner | Our Commercial Rights | Discovery | Preclinical | IND- enabling | Phase I | Phase IIa |
|---|---|---|---|---|---|---|---|---|---|
| PRS-352 | n.d./n.d. Bispecific |
Immuno-Oncology |  |  |
Discovery Phase completed
|
Pre-Clinical Phase in progress
|
IND-enabling Phase not started
|
Phase 1 not started
|
Phase 2 not started
|